Asciminib monotherapy in patients with CML-CP without BCR::ABL1 T315I mutations treated with at least two prior TKIs: 4-year phase 1 safety and efficacy results

Mauro, Michael J., Hughes, Timothy P., Kim, Dong-Wook · Leukemia · 2023